EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
21,684,000
Total 13F shares
8,613,995
Share change
-332,769
Total reported value
$129,154,810
Price per share
$14.99
Number of holders
54
Value change
-$7,053,554
Number of buys
34
Number of sells
27

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q2 2021

As of 30 Jun 2021, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,613,995 shares. The largest 10 holders included WASATCH ADVISORS INC, RTW INVESTMENTS, LP, COWEN AND COMPANY, LLC, BlackRock Inc., VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, Nantahala Capital Management, LLC, MORGAN STANLEY, NOMURA HOLDINGS INC, and SILVERCREST ASSET MANAGEMENT GROUP LLC. This page lists 54 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.